CANCON - WP 5 Dissemination meeting CANCON and Member States: How - - PowerPoint PPT Presentation

CANCON - WP 5

Dissemination meeting

Giovanni Nicoletti Brussels | 23 February 2016

CANCON and Member States: How can we collaborate

KEY DELIVERABLE

A set of “Policy (Position) Papers” focusing

“hot themes” on cancer control policies (rather than “scientific” issues)

Agreement: Due to restriction in time/resources a limited

number of topics will be handled (5 topics in total).

WP 5 Objective

• The overall objective of the platform is to invite Member

States (MSs) to share about the different challenges they are facing and their experiences, which are a valuable lesson for others.

• In addition, sharing knowledge and information can help

to solve some of the difficulties that MSs are facing in an ever more complex cancer prevention and control area.

PARTNERS OF THE WP

• Belgian Cancer Centre, Scientific Institute of Public Health , WIV-ISP (CO-LEADER)
• Università di Roma La Sapienza-Italy (Supporting MoH IT)
• Federal Ministry of Health, FOD
• National Institute of Public Health – Slovenia
• SloveniaInstitute of Oncology Cluj - Napoca IOCN – Romania
• [Riga University Hospital REUH - Latvia ]
• Ministry of health, social services and equality MSSSI– Spain
• Portugal : TBD; CP IPOS host of a subgroup workshop

KEY DELIVERABLE

A “policy (position) paper” * is an essay that presents an opinion/appraisal about an issue.

As a deliverable of the platform, it:

• summarizes the main aspects of a given topics that

makes explicit the aspects MSs agree to consider important

• openly identifies possible issues in defining a policy at

a MS level,

• suggests recommendations about advocated policies

* Final wording to be adjusted in agreement with all MS: may be Policy Paper

SELECTION OF TOPICS Criteria for selection

• MS Scoring Survey
• Singular MS willingness to carry a topic out
• Stakeholder suggestions

SELECTED TOPICS

Writing Group leader

Common European objectives for National Cancer Control Plans

Slovenia (T. Albreht)

A system for assessing and promoting the disinvestment process for re-allocation

Italy

• A. Federici

A Public health genomics approach to “omics” in

• ncology

Belgium

• M. Van

denBulcke

An impact evaluation system to assess prevention

• utcomes

Italy

• G. La Torre

Equity mainstreaming in the cancer control in Europe

Spain Rosana Peirò

SEARCH THE EVIDENCE

Accordingly to the mandate of the WP, evidence is relevant in the perspective of making a “policy”; therefore it should include (when appropriate):

• Secondary level scientific evidence (guide-lines

etc): hopefully not primary or not-confirmed data

• Qualitative data, mainly about the policies already

put in place by Countries

• Possible economic or socio-demographic data

DRAFT 1 OUTPUT

DELIVERABLES

PRE DRAFTING DRAFT 1 DRAFT 2 DRAFT 3

Search of relevant evidence Evidence and issues established Contents agreed with ind.experts Policies submitted to Platform

Position paper

GENERAL DISCUSSION

We are: here

WP 5 Interaction with MS

• MS Representatives in CANCON
• The Commission Expert Group on CANCER

CONTROL

• The MS Platform e-tool

Key points: The target group of this position paper is senior policy makers! Thus: provide guidance on how to install a system that brings research into the health care system

• who pays what
• clinical utility driven approaches

POLICY PAPER ON PUBLIC HEALTH GENOMICS

→ Translating New Genomic Discoveries into Practice and

assessing their Impact on Providers, Patients and the Public's Health: need for an EU approach

Belgian test case → Stratified cancer screening? Germany → “Direct to consumer” cancer testing

?

→

POLICY PAPER ON PUBLIC HEALTH GENOMICS

POLICY PAPER ON NATIONAL CANCER CONTROL PROGRAMMES

• EPAAC provided two important deliverables in its exploration of

national cancer control plans/programmes/strategies:

• A survey of all MS, EEA and candidate countries on their current

status of these documents

• A European guide on how to approach the preparation of a

planning document for cancer care and management

• CANCON is going to review the developments and experiences of

MSs

• New survey carried out , more systematically prepared
• Afterwards a report will be prepared encompassing the current state-
• f-play and also the difference between the situation in 2011 and

today

• Finally, the policy paper will build on the positive experiences and

developments of MSs in order to provide recommendations and guidance in cancer plans and strategies for both the European Commission and the MSs

POLICY PAPER ON NATIONAL CANCER CONTROL PROGRAMMES

• “..the process of (partially or completely) withdrawing resources

from any existing health practices, procedures, technologies or pharmaceuticals that are deemed to deliver little or no health gain for their cost, and thus are not efficient health resources allocation”

POLICY PAPER ON DISINVESTMENT AND REALLOCATION

• To provide participating countries with a

document outlining the issues to be considered when adopting disinvestment policies in oncology

• A general guidance on how disinvestment

policies could be framed, to maximize their potential

DISINVESTMENT AND REALLOCATION : THE GOALS

• Distinguishing “disinvestment for reallocation”

from mere resource cutting

• Definition of diagnostic/therapeutic interventions
• f interest
• Stakeholders’engagement and motivation (health

professionals, patients/citizen)

• The relevance of international collaboration
• Possible priority areas in cancer care (i.e those

that could benefit the most from disinvestment policies)

DISINVESTMENT AND REALLOCATION : THE ISSUES

WP 5

The draft will be presented at the beginning of April. The report

contains the first data that synthetize some characteristics of polices/interventions reviewed in the literatures for each four topic. The data will be focused on:

• Policy/intervention typology
• Setting
• Target population
• Outcomes: behavior, knowledge or health.
• Indicators applied to measure the effectiveness
• Effectiveness of polices/intervention found with the different

indicators (yes, no, unclear)

• At the end of April the draft will be agreed with the Experts
• In September the final position paper.

POLICY PAPER ON PREVENTION OUTCOME

• This policy paper aims to provide very practical

recommendations to embed equity actions within National Cancer Plans, cancer prevention and cancer control policies in Europe, underpinned by the experiences that have been learned in different Member States (MS).

• As a parallel objective all the compiled evidence will be

publish in a scientific paper

POLICY PAPER ON TACKLING INEQUALITIES IN CANCER PROGRAMMES

• This policy paper aims to provide very practical

recommendations to embed equity actions within National Cancer Plans, cancer prevention and cancer control policies in Europe, underpinned by the experiences that have been learned in different Member States (MS).

• As a parallel objective all the compiled evidence will be

publish in a scientific paper

Tackling Social Inequalities in Cancer

prevention and control for European citizens

European Level Member States level Public Health and Health Care provision

Equity in cancer strategy;

Cancer inequalities evidence; Health promotion and cancer prevention policies; Health in all policies; Train Cancer professional in equity; Community and patients participation

Scope potential health

disadvantaged groups; asses

the Impact of cancer prevention

programmes, care and rehabilitation services on each of the populations affected; Develop a Comprehensive

Citizen-Focused Strategy; Monitoring and Evaluation

To develop a European

strategy that provides visibility and awareness of the existence of cancer inequalities in the cancer

continuum. Policy recommendations related to Research Programmes, Benchmarking Best experiences and Professional Exchanges for the improvement of Professional Competences. Quality linked to equity. Human rights Health equity Life course approach Patient centred Dignity

Key issues of the policy paper

WP 5 Next Steps

• Finalizing discussion with MS (late Autumn)
• Presentation in Malta CANCON Final

Conference (Malta 2017)

• Information to the Council (WPPH-SL ?)

Thank You